MELLISSA GOSSET: Open Payments
NPI 1164052478 · PAWTUCKET, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,717 in 97 payments from 23 companies in 2025. Trend: 2023 $1,594 · 2024 $1,967 · 2025 $3,717
Food & beverage: $3,717
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $801 |
| ABBVIE INC. | 17 | $738 |
| Abbott Laboratories | 5 | $672 |
| Novo Nordisk Inc | 7 | $328 |
| Ardelyx, Inc. | 7 | $182 |
| Phathom Pharmaceuticals, Inc. | 3 | $155 |
| GlaxoSmithKline, LLC. | 6 | $116 |
| PFIZER INC. | 4 | $107 |
| Amgen Inc. | 4 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $103 |
Products named: FREESTYLE LIBRE 3, VRAYLAR, BREZTRI, Ozempic, AIRSUPRA, IBSRELA, FARXIGA, VOQUEZNA.
Industry payments across RI — which companies pay providers there.
